Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Charles Sherr

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Mice

Chemicals & Drugs

Physiology

Anatomy

Concepts & Ideas

Molecular Sequence Data

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
71
Roussel, Martine
25
Zindy, Frederique
14
Ashmun, RA
12
Downing, James
10
Shurtleff, Sheila
9
Rehg, Jerold
8
Quelle, Dawn
8
Kuo, Mei-Ling
8
Williams, Richard
8
den Besten, Willem
7
Weber, Jason D.
7
Diehl, Alan
7
Cleveland, John
5
Bertwistle, David
5
Kamijo, T

Sign-in to see all Coauthors

Publications

TOP 3
Gromley Adam; Churchman Michelle L; Zindy Frederique; Sherr Charles J
Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice.
Ayrault Olivier; Zindy Frederique; Rehg Jerold; Sherr Charles J; Roussel Martine F
Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma.
Mullighan Charles G; Williams Richard T; Downing James R; Sherr Charles J
Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Charles Sherr (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gromley Adam; Churchman Michelle L; Zindy Frederique; Sherr Charles J
Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(15):6285-90.
2009: Ayrault Olivier; Zindy Frederique; Rehg Jerold; Sherr Charles J; Roussel Martine F
Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma.
Molecular cancer research : MCR 2009;7(1):33-40.
2008: Mullighan Charles G; Williams Richard T; Downing James R; Sherr Charles J
Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL.
Genes & development 2008;22(11):1411-5.
2007: Williams Richard T; den Besten Willem; Sherr Charles J
Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia.
Genes & development 2007;21(18):2283-7.
2007: Zindy Frederique; Uziel Tamar; Ayrault Olivier; Calabrese Christopher; Valentine Marc; Rehg Jerold E; Gilbertson Richard J; Sherr Charles J; Roussel Martine F
Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.
Cancer research 2007;67(6):2676-84.
2007: Bertwistle David; Sherr Charles J
Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis.
Blood 2007;109(2):792-4.
2007: Williams Richard T; Sherr Charles J
The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.
Advances in experimental medicine and biology 2007;604():107-14.
2006: Sherr Charles J
Divorcing ARF and p53: an unsettled case.
Nature reviews. Cancer 2006;6(9):663-73.
2006: Zindy Frederique; Knoepfler Paul S; Xie Suqing; Sherr Charles J; Eisenman Robert N; Roussel Martine F
N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(31):11579-83.
2006: Sherr Charles J
Autophagy by ARF: a short story.
Molecular cell 2006;22(4):436-7.
2006: den Besten Willem; Kuo Mei-Ling; Tago Kenji; Williams Richard T; Sherr Charles J
Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
The Israel Medical Association journal : IMAJ 2006;8(4):249-51.
2006: Williams Richard T; Roussel Martine F; Sherr Charles J
Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(17):6688-93.
2006: Uziel Tamar; Zindy Frederique; Sherr Charles J; Roussel Martine F
The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma.
Cell cycle (Georgetown, Tex.) 2006;5(4):363-5.
2006: Sugimoto Masataka; Gromley Adam; Sherr Charles J
Hzf, a p53-responsive gene, regulates maintenance of the G2 phase checkpoint induced by DNA damage.
Molecular and cellular biology 2006;26(2):502-12.
2005: Jerome-Majewska Loydie A; Jenkins Gerard P; Ernstoff Elana; Zindy Frederique; Sherr Charles J; Papaioannou Virginia E
Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway.
Developmental dynamics : an official publication of the American Association of Anatomists 2005;234(4):922-33.
2005: Uziel Tamar; Zindy Frederique; Xie Suqing; Lee Youngsoo; Forget Antoine; Magdaleno Susan; Rehg Jerold E; Calabrese Christopher; Solecki David; Eberhart Charles G; Sherr Sarah E; Plimmer Sarah; Clifford Steven C; Hatten Mary E; McKinnon Peter J; Gilbertson Richard J; Curran Tom; Sherr Charles J; Roussel Martine F
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.
Genes & development 2005;19(22):2656-67.
2005: den Besten Willem; Kuo Mei-Ling; Williams Richard T; Sherr Charles J
Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
Cell cycle (Georgetown, Tex.) 2005;4(11):1593-8.
2005: Tago Kenji; Chiocca Susanna; Sherr Charles J
Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(21):7689-94.
2005: Sherr C J; Bertwistle D; DEN Besten W; Kuo M-L; Sugimoto M; Tago K; Williams R T; Zindy F; Roussel M F
p53-Dependent and -independent functions of the Arf tumor suppressor.
Cold Spring Harbor symposia on quantitative biology 2005;70():129-37.
2004: Sherr Charles J; Roberts James M
Living with or without cyclins and cyclin-dependent kinases.
Genes & development 2004;18(22):2699-711.
2004: Kuo Mei-Ling; den Besten Willem; Sherr Charles J
N-Terminal polyubiquitination of the ARF tumor suppressor, a natural lysine-less protein.
Cell cycle (Georgetown, Tex.) 2004;3(11):1367-9.
2004: Bertwistle David; Zindy Frederique; Sherr Charles J; Roussel Martine F
Monoclonal antibodies to the mouse p19(Arf) tumor suppressor protein.
Hybridoma and hybridomics 2004;23(5):293-300.
2004: Cleveland John L; Sherr Charles J
Antagonism of Myc functions by Arf.
Cancer cell 2004;6(4):309-11.
2004: Kuo Mei-Ling; den Besten Willem; Bertwistle David; Roussel Martine F; Sherr Charles J
N-terminal polyubiquitination and degradation of the Arf tumor suppressor.
Genes & development 2004;18(15):1862-74.
2004: Sherr Charles J
An Arf(GFP/GFP) reporter mouse reveals that the Arf tumor suppressor monitors latent oncogenic signals in vivo.
Cell cycle (Georgetown, Tex.) 2004;3(3):239-40.
2004: Bertwistle David; Sugimoto Masataka; Sherr Charles J
Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.
Molecular and cellular biology 2004;24(3):985-96.
2004: Sherr Charles J
Principles of tumor suppression.
Cell 2004;116(2):235-46.
2003: Zindy Frederique; Williams Richard T; Baudino Troy A; Rehg Jerold E; Skapek Stephen X; Cleveland John L; Roussel Martine F; Sherr Charles J
Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(26):15930-5.
2003: Zindy Frederique; Nilsson Lisa M; Nguyen Luc; Meunier Cecile; Smeyne Richard J; Rehg Jerold E; Eberhart Charles; Sherr Charles J; Roussel Martine F
Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice.
Cancer research 2003;63(17):5420-7.
2003: Baudino Troy A; Maclean Kirsteen H; Brennan Jennifer; Parganas Evan; Yang Chunying; Aslanian Aaron; Lees Jacqueline A; Sherr Charles J; Roussel Martine F; Cleveland John L
Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
Molecular cell 2003;11(4):905-14.
2003: Kuo Mei-Ling; Duncavage Eric J; Mathew Rose; den Besten Willem; Pei Deqing; Naeve Deanna; Yamamoto Tadashi; Cheng Cheng; Sherr Charles J; Roussel Martine F
Arf induces p53-dependent and -independent antiproliferative genes.
Cancer research 2003;63(5):1046-53.
2003: Sugimoto Masataka; Kuo Mei-Ling; Roussel Martine F; Sherr Charles J
Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.
Molecular cell 2003;11(2):415-24.
2003: Lowe Scott W; Sherr Charles J
Tumor suppression by Ink4a-Arf: progress and puzzles.
Current opinion in genetics & development 2003;13(1):77-83.
2002: Sherr Charles J; McCormick Frank
The RB and p53 pathways in cancer.
Cancer cell 2002;2(2):103-12.
2002: Dang Jinjun; Kuo Mei-Ling; Eischen Christine M; Stepanova Lilia; Sherr Charles J; Roussel Martine F
The RING domain of Mdm2 can inhibit cell proliferation.
Cancer research 2002;62(4):1222-30.
2001: Inoue K; Zindy F; Randle D H; Rehg J E; Sherr C J
Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas.
Genes & development 2001;15(22):2934-9.
2001: Sherr C J
The INK4a/ARF network in tumour suppression.
Nature reviews. Molecular cell biology 2001;2(10):731-7.
2001: Sherr C J
Parsing Ink4a/Arf: "pure" p16-null mice.
Cell 2001;106(5):531-4.
2001: Randle D H; Zindy F; Sherr C J; Roussel M F
Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(17):9654-9.
2001: Zindy F; den Besten W; Chen B; Rehg J E; Latres E; Barbacid M; Pollard J W; Sherr C J; Cohen P E; Roussel M F
Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).
Molecular and cellular biology 2001;21(9):3244-55.
2000: Weber J D; Jeffers J R; Rehg J E; Randle D H; Lozano G; Roussel M F; Sherr C J; Zambetti G P
p53-independent functions of the p19(ARF) tumor suppressor.
Genes & development 2000;14(18):2358-65.
2000: Groth A; Weber J D; Willumsen B M; Sherr C J; Roussel M F
Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases.
The Journal of biological chemistry 2000;275(35):27473-80.
2000: Sherr C J; DePinho R A
Cellular senescence: mitotic clock or culture shock?
Cell 2000;102(4):407-10.
2000: Sherr C J
The Pezcoller lecture: cancer cell cycles revisited.
Cancer research 2000;60(14):3689-95.
2000: Inoue K; Wen R; Rehg J E; Adachi M; Cleveland J L; Roussel M F; Sherr C J
Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.
Genes & development 2000;14(14):1797-809.
2000: Weber J D; Kuo M L; Bothner B; DiGiammarino E L; Kriwacki R W; Roussel M F; Sherr C J
Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.
Molecular and cellular biology 2000;20(7):2517-28.
2000: Sherr C J; Weber J D
The ARF/p53 pathway.
Current opinion in genetics & development 2000;10(1):94-9.
2000: Zindy F; van Deursen J; Grosveld G; Sherr C J; Roussel M F
INK4d-deficient mice are fertile despite testicular atrophy.
Molecular and cellular biology 2000;20(1):372-8.
2000: Sherr C J
Cell cycle control and cancer.
Harvey lectures 2000;96():73-92.
1999: Zindy F; Cunningham J J; Sherr C J; Jogal S; Smeyne R J; Roussel M F
Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(23):13462-7.
1999: Eischen C M; Weber J D; Roussel M F; Sherr C J; Cleveland J L
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
Genes & development 1999;13(20):2658-69.
1999: Brewer J W; Hendershot L M; Sherr C J; Diehl J A
Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(15):8505-10.
1999: Sherr C J; Roberts J M
CDK inhibitors: positive and negative regulators of G1-phase progression.
Genes & development 1999;13(12):1501-12.
1999: Weber J D; Taylor L J; Roussel M F; Sherr C J; Bar-Sagi D
Nucleolar Arf sequesters Mdm2 and activates p53.
Nature cell biology 1999;1(1):20-6.
1999: Kamijo T; van de Kamp E; Chong M J; Zindy F; Diehl J A; Sherr C J; McKinnon P J
Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.
Cancer research 1999;59(10):2464-9.
1999: Kamijo T; Bodner S; van de Kamp E; Randle D H; Sherr C J
Tumor spectrum in ARF-deficient mice.
Cancer research 1999;59(9):2217-22.
1999: Inoue K; Roussel M F; Sherr C J
Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(7):3993-8.
1999: Cheng M; Olivier P; Diehl J A; Fero M; Roussel M F; Roberts J M; Sherr C J
The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.
The EMBO journal 1999;18(6):1571-83.
1999: Sexl V; Diehl J A; Sherr C J; Ashmun R; Beach D; Roussel M F
A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2.
Oncogene 1999;18(3):573-82.
1998: Diehl J A; Cheng M; Roussel M F; Sherr C J
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.
Genes & development 1998;12(22):3499-511.
1998: Inoue K; Sherr C J; Shapiro L H
Regulation of the CD13/aminopeptidase N gene by DMP1, a transcription factor antagonized by D-type cyclins.
The Journal of biological chemistry 1998;273(44):29188-94.
1998: Sherr C J
Tumor surveillance via the ARF-p53 pathway.
Genes & development 1998;12(19):2984-91.
1998: de Stanchina E; McCurrach M E; Zindy F; Shieh S Y; Ferbeyre G; Samuelson A V; Prives C; Roussel M F; Sherr C J; Lowe S W
E1A signaling to p53 involves the p19(ARF) tumor suppressor.
Genes & development 1998;12(15):2434-42.
1998: Zindy F; Eischen C M; Randle D H; Kamijo T; Cleveland J L; Sherr C J; Roussel M F
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.
Genes & development 1998;12(15):2424-33.
1998: Kamijo T; Weber J D; Zambetti G; Zindy F; Roussel M F; Sherr C J
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(14):8292-7.
1998: Inoue K; Sherr C J
Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism.
Molecular and cellular biology 1998;18(3):1590-600.
1998: Cheng M; Sexl V; Sherr C J; Roussel M F
Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).
Proceedings of the National Academy of Sciences of the United States of America 1998;95(3):1091-6.
1997: Diehl J A; Sherr C J
A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase.
Molecular and cellular biology 1997;17(12):7362-74.
1997: Kamijo T; Zindy F; Roussel M F; Quelle D E; Downing J R; Ashmun R A; Grosveld G; Sherr C J
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.
Cell 1997;91(5):649-59.
1997: Zindy F; Soares H; Herzog K H; Morgan J; Sherr C J; Roussel M F
Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(11):1139-50.
1997: Zindy F; Quelle D E; Roussel M F; Sherr C J
Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.
Oncogene 1997;15(2):203-11.
1997: Diehl J A; Zindy F; Sherr C J
Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
Genes & development 1997;11(8):957-72.
1997: Quelle D E; Cheng M; Ashmun R A; Sherr C J
Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(2):669-73.
1996: Sherr C J
Cancer cell cycles.
Science (New York, N.Y.) 1996;274(5293):1672-7.
1996: Hirai H; Sherr C J
Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1.
Molecular and cellular biology 1996;16(11):6457-67.
1996: Roussel M F; Ashmun R A; Sherr C J; Eisenman R N; Ayer D E
Inhibition of cell proliferation by the Mad1 transcriptional repressor.
Molecular and cellular biology 1996;16(6):2796-801.
1995: Quelle D E; Zindy F; Ashmun R A; Sherr C J
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest.
Cell 1995;83(6):993-1000.
1995: Okuda T; Hirai H; Valentine V A; Shurtleff S A; Kidd V J; Lahti J M; Sherr C J; Downing J R
Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases.
Genomics 1995;29(3):623-30.
1995: Quelle D E; Ashmun R A; Hannon G J; Rehberger P A; Trono D; Richter K H; Walker C; Beach D; Sherr C J; Serrano M
Cloning and characterization of murine p16INK4a and p15INK4b genes.
Oncogene 1995;11(4):635-45.
1995: Roussel M F; Theodoras A M; Pagano M; Sherr C J
Rescue of defective mitogenic signaling by D-type cyclins.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(15):6837-41.
1995: Sherr C J; Roberts J M
Inhibitors of mammalian G1 cyclin-dependent kinases.
Genes & development 1995;9(10):1149-63.
1995: Hirai H; Roussel M F; Kato J Y; Ashmun R A; Sherr C J
Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
Molecular and cellular biology 1995;15(5):2672-81.
1995: Okuda T; Shurtleff S A; Valentine M B; Raimondi S C; Head D R; Behm F; Curcio-Brint A M; Liu Q; Pui C H; Sherr C J
Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.
Blood 1995;85(9):2321-30.
1994: Sherr C J
G1 phase progression: cycling on cue.
Cell 1994;79(4):551-5.
1994: Kato J Y; Matsuoka M; Polyak K; Massagué J; Sherr C J
Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.
Cell 1994;79(3):487-96.
1994: Matsuoka M; Kato J Y; Fisher R P; Morgan D O; Sherr C J
Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase.
Molecular and cellular biology 1994;14(11):7265-75.
1994: Kato J Y; Matsuoka M; Strom D K; Sherr C J
Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase.
Molecular and cellular biology 1994;14(4):2713-21.
1994: Matsushime H; Quelle D E; Shurtleff S A; Shibuya M; Sherr C J; Kato J Y
D-type cyclin-dependent kinase activity in mammalian cells.
Molecular and cellular biology 1994;14(3):2066-76.
1994: Vallance S J; Lee H M; Roussel M F; Shurtleff S A; Kato J Y; Strom D K; Sherr C J
Monoclonal antibodies to mammalian D-type G1 cyclins.
Hybridoma 1994;13(1):37-44.
1994: Polyak K; Kato J Y; Solomon M J; Sherr C J; Massague J; Roberts J M; Koff A
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
Genes & development 1994;8(1):9-22.
1994: Sherr C J; Kato J; Quelle D E; Matsuoka M; Roussel M F
D-type cyclins and their cyclin-dependent kinases: G1 phase integrators of the mitogenic response.
Cold Spring Harbor symposia on quantitative biology 1994;59():11-9.
1993: Kato J Y; Sherr C J
Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(24):11513-7.
1993: Khatib Z A; Matsushime H; Valentine M; Shapiro D N; Sherr C J; Look A T
Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.
Cancer research 1993;53(22):5535-41.
1993: Quelle D E; Ashmun R A; Shurtleff S A; Kato J Y; Bar-Sagi D; Roussel M F; Sherr C J
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
Genes & development 1993;7(8):1559-71.
1993: Sherr C J
Mammalian G1 cyclins.
Cell 1993;73(6):1059-65.
1993: Ewen M E; Sluss H K; Sherr C J; Matsushime H; Kato J; Livingston D M
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.
Cell 1993;73(3):487-97.
1993: Kato J; Matsushime H; Hiebert S W; Ewen M E; Sherr C J
Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.
Genes & development 1993;7(3):331-42.
1992: Matsushime H; Ewen M E; Strom D K; Kato J Y; Hanks S K; Roussel M F; Sherr C J
Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.
Cell 1992;71(2):323-34.
1992: Inaba T; Matsushime H; Valentine M; Roussel M F; Sherr C J; Look A T
Genomic organization, chromosomal localization, and independent expression of human cyclin D genes.
Genomics 1992;13(3):565-74.
1992: van Daalen Wetters T; Hawkins S A; Roussel M F; Sherr C J
Random mutagenesis of CSF-1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain.
The EMBO journal 1992;11(2):551-7.
1992: Sherr C J; Matsushime H; Roussel M F
Regulation of CYL/cyclin D genes by colony-stimulating factor 1.
Ciba Foundation symposium 1992;170():209-19; discussion 219-26.
1991: Sherr C J
Mitogenic response to colony-stimulating factor 1.
Trends in genetics : TIG 1991;7(11-12):398-402.
1991: Roussel M F; Cleveland J L; Shurtleff S A; Sherr C J
Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling.
Nature 1991;353(6342):361-3.
1991: Matsushime H; Roussel M F; Matsushima K; Hishinuma A; Sherr C J
Cloning and expression of murine interleukin-1 receptor antagonist in macrophages stimulated by colony-stimulating factor 1.
Blood 1991;78(3):616-23.
1991: Kato J; Sherr C J
A dominant suppressive mutation in a cellular gene restores the nontransformed phenotype to v-fms-transformed mink cells.
Oncogene 1991;6(5):687-93.
1991: Matsushime H; Roussel M F; Ashmun R A; Sherr C J
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.
Cell 1991;65(4):701-13.
1991: Downing J R; Shurtleff S A; Sherr C J
Peptide antisera to human colony-stimulating factor 1 receptor detect ligand-induced conformational changes and a binding site for phosphatidylinositol 3-kinase.
Molecular and cellular biology 1991;11(5):2489-95.
1991: Sherr C J; Borzillo G V; Kato J; Shurtleff S A; Downing J R; Roussel M F
Regulation of cell growth and differentiation by the colony-stimulating factor 1 receptor.
Seminars in hematology 1991;28(2):143-51.
1991: Matsushime H; Roussel M F; Sherr C J
Novel mammalian cyclins (CYL genes) expressed during G1.
Cold Spring Harbor symposia on quantitative biology 1991;56():69-74.
1990: Roussel M F; Shurtleff S A; Downing J R; Sherr C J
A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of c-fos and junB genes.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(17):6738-42.
1990: Shurtleff S A; Downing J R; Rock C O; Hawkins S A; Roussel M F; Sherr C J
Structural features of the colony-stimulating factor 1 receptor that affect its association with phosphatidylinositol 3-kinase.
The EMBO journal 1990;9(8):2415-21.
1990: Borzillo G V; Ashmun R A; Sherr C J
Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes.
Molecular and cellular biology 1990;10(6):2703-14.
1990: Kato J; Sherr C J
Human colony-stimulating factor 1 (CSF-1) receptor confers CSF-1 responsiveness to interleukin-3-dependent 32DC13 mouse myeloid cells and abrogates differentiation in response to granulocyte CSF.
Blood 1990;75(9):1780-7.
1990: Roussel M F; Transy C; Kato J Y; Reinherz E L; Sherr C J
Antibody-induced mitogenicity mediated by a chimeric CD2-c-fms receptor.
Molecular and cellular biology 1990;10(5):2407-12.
1990: Ohtsuka M; Roussel M F; Sherr C J; Downing J R
Ligand-induced phosphorylation of the colony-stimulating factor 1 receptor can occur through an intermolecular reaction that triggers receptor down modulation.
Molecular and cellular biology 1990;10(4):1664-71.
1990: Sherr C J
Regulation of mononuclear phagocyte proliferation by colony-stimulating factor-1.
International journal of cell cloning 1990;8 Suppl 1():46-60; discussion 60-2.
1990: Roussel M F; Downing J R; Sherr C J
Transforming activities of human CSF-1 receptors with different point mutations at codon 301 in their extracellular domains.
Oncogene 1990;5(1):25-30.
1990: Sherr C J
Colony-stimulating factor-1 receptor.
Blood 1990;75(1):1-12.
1990: Sherr C J; Kato J Y; Borzillo G; Downing J R; Roussel M F
Signal-response coupling mediated by the transduced colony-stimulating factor-1 receptor and its oncogenic fms variants in naive cells.
Ciba Foundation symposium 1990;148():96-104; discussion 104-9.
1990: Sherr C J
The colony-stimulating factor 1 receptor: pleiotropy of signal-response coupling.
Lymphokine research 1990;9(4):543-8.
1989: Downing J R; Margolis B L; Zilberstein A; Ashmun R A; Ullrich A; Sherr C J; Schlessinger J
Phospholipase C-gamma, a substrate for PDGF receptor kinase, is not phosphorylated on tyrosine during the mitogenic response to CSF-1.
The EMBO journal 1989;8(11):3345-50.
1989: Roussel M F; Sherr C J
Mouse NIH 3T3 cells expressing human colony-stimulating factor 1 (CSF-1) receptors overgrow in serum-free medium containing human CSF-1 as their only growth factor.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(20):7924-7.
1989: Borzillo G V; Sherr C J
Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures.
Molecular and cellular biology 1989;9(9):3973-81.
1989: Rettenmier C W; Sherr C J
The mononuclear phagocyte colony-stimulating factor (CSF-1, M-CSF).
Hematology/oncology clinics of North America 1989;3(3):479-93.
1989: Kato J Y; Roussel M F; Ashmun R A; Sherr C J
Transduction of human colony-stimulating factor-1 (CSF-1) receptor into interleukin-3-dependent mouse myeloid cells induces both CSF-1-dependent and factor-independent growth.
Molecular and cellular biology 1989;9(9):4069-73.
1989: Ashmun R A; Look A T; Roberts W M; Roussel M F; Seremetis S; Ohtsuka M; Sherr C J
Monoclonal antibodies to the human CSF-1 receptor (c-fms proto-oncogene product) detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells.
Blood 1989;73(3):827-37.
1988: Roussel M F; Downing J R; Rettenmier C W; Sherr C J
A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential.
Cell 1988;55(6):979-88.
1988: Sherr C J
The role of the CSF-1 receptor gene (C-fms) in cell transformation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(12 Suppl):132S-142S.
1988: Sherr C J; Roussel M F; Rettenmier C W
Colony-stimulating factor-1 receptor (c-fms).
Journal of cellular biochemistry 1988;38(3):179-87.
1988: Roberts W M; Look A T; Roussel M F; Sherr C J
Tandem linkage of human CSF-1 receptor (c-fms) and PDGF receptor genes.
Cell 1988;55(4):655-61.
1988: Roussel M F; Downing J R; Ashmun R A; Rettenmier C W; Sherr C J
Colony-stimulating factor 1-mediated regulation of a chimeric c-fms/v-fms receptor containing the v-fms-encoded tyrosine kinase domain.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(16):5903-7.
1988: Roussel M F; Rettenmier C W; Sherr C J
Introduction of a human colony stimulating factor-1 gene into a mouse macrophage cell line induces CSF-1 independence but not tumorigenicity.
Blood 1988;71(5):1218-25.
1988: Downing J R; Rettenmier C W; Sherr C J
Ligand-induced tyrosine kinase activity of the colony-stimulating factor 1 receptor in a murine macrophage cell line.
Molecular and cellular biology 1988;8(4):1795-9.
1988: Rettenmier C W; Roussel M F; Sherr C J
The colony-stimulating factor 1 (CSF-1) receptor (c-fms proto-oncogene product) and its ligand.
Journal of cell science. Supplement 1988;9():27-44.
1988: Sherr C J; Rettenmier C W; Roussel M F
Macrophage colony-stimulating factor, CSF-1, and its proto-oncogene-encoded receptor.
Cold Spring Harbor symposia on quantitative biology 1988;53 Pt 1():521-30.
1987: Heard J M; Roussel M F; Rettenmier C W; Sherr C J
Multilineage hematopoietic disorders induced by transplantation of bone marrow cells expressing the v-fms oncogene.
Cell 1987;51(4):663-73.
1987: Heard J M; Roussel M F; Rettenmier C W; Sherr C J
Synthesis, post-translational processing, and autocrine transforming activity of a carboxylterminal truncated form of colony stimulating factor-1.
Oncogene research 1987;1(4):423-40.
1987: Rettenmier C W; Roussel M F; Ashmun R A; Ralph P; Price K; Sherr C J
Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes.
Molecular and cellular biology 1987;7(7):2378-87.
1987: Sherr C J
Fibroblast and hematopoietic cell transformation by the fms oncogene (CSF-1 receptor).
Journal of cellular physiology. Supplement 1987;Suppl 5():83-7.
1986: Wheeler E F; Rettenmier C W; Look A T; Sherr C J
The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line.
Nature 1986;324(6095):377-80.
1986: Wheeler E F; Roussel M F; Hampe A; Walker M H; Fried V A; Look A T; Rettenmier C W; Sherr C J
The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences.
Journal of virology 1986;59(2):224-33.
1986: Rettenmier C W; Roussel M F; Wheeler E F; Sherr C J
Requirements for transformation by the fms oncogene product (CSF-1 receptor).
Princess Takamatsu symposia 1986;17():211-8.

Sign-in to see more